Robbins Andrews R
Insider CIK 1590157 · ARRY SVP, Commercial Operations · COGT President and CEO, Director · HARP Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| COGT Cogent Biosciences, Inc. | G Gift | 2026-05-19 | 2026-05-21 | 160,000 | — | $0 | 497,503 | SEC↗ |
| COGT Cogent Biosciences, Inc. | G Gift | 2026-05-19 | 2026-05-21 | 160,000 | — | $0 | 160,000 | SEC↗ |
| COGT Cogent Biosciences, Inc. | A Award deriv | 2025-12-17 | 2025-12-19 | 245,000 | — | $0 | 245,000 | SEC↗ |
| COGT Cogent Biosciences, Inc. | A Award | 2025-12-17 | 2025-12-19 | 840,000 | — | $0 | 1,025,000 | SEC↗ |
| COGT Cogent Biosciences, Inc. | A Award | 2025-12-17 | 2025-12-19 | 185,000 | — | $0 | 185,000 | SEC↗ |
| COGT Cogent Biosciences, Inc. | F Tax w/h | 2025-12-17 | 2025-12-19 | 367,497 | $39.45 | $14.50M | 657,503 | SEC↗ |
| COGT Cogent Biosciences, Inc. | A Award deriv | 2025-01-23 | 2025-01-27 | 915,000 | — | $0 | 915,000 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | D To issuer deriv | 2024-03-11 | 2024-03-11 | 2,300 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | D To issuer deriv | 2024-03-11 | 2024-03-11 | 1,016 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | D To issuer | 2024-03-11 | 2024-03-11 | 5,000 | — | $0 | 0 | SEC↗ |
| COGT Cogent Biosciences, Inc. | A Award deriv | 2024-01-23 | 2024-01-25 | 1,100,000 | — | $0 | 1,100,000 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award | 2023-11-27 | 2023-11-28 | 5,000 | — | $0 | 5,000 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award deriv | 2023-06-22 | 2023-06-23 | 23,000 | — | $0 | 23,000 | SEC↗ |
| COGT Cogent Biosciences, Inc. | A Award deriv | 2023-02-13 | 2023-02-15 | 525,000 | — | $0 | 525,000 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award deriv | 2022-06-22 | 2022-06-24 | 10,167 | — | $0 | 10,167 | SEC↗ |
| COGT Cogent Biosciences, Inc. | A Award deriv | 2022-01-25 | 2022-01-27 | 690,000 | $4.94 | $3.41M | 690,000 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award deriv | 2021-05-04 | 2021-05-07 | 10,167 | — | $0 | 10,167 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award deriv | 2021-05-04 | 2021-05-14 | 10,167 | — | $0 | 10,167 | SEC↗ |
| COGT Cogent Biosciences, Inc. | A Award deriv | 2021-02-10 | 2021-02-12 | 315,200 | — | $0 | 315,200 | SEC↗ |
| COGT Cogent Biosciences, Inc. | A Award deriv | 2020-12-07 | 2020-12-09 | 456,693 | — | $0 | 456,693 | SEC↗ |
| COGT Cogent Biosciences, Inc. | A Award deriv | 2020-10-23 | 2020-10-27 | 7,442,421 | — | $0 | 7,442,421 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award deriv | 2020-03-30 | 2020-04-01 | 20,335 | — | $0 | 20,335 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | D To issuer deriv | 2019-07-30 | 2019-07-30 | 236,250 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | D To issuer deriv | 2019-07-30 | 2019-07-30 | 12,500 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | D To issuer deriv | 2019-07-30 | 2019-07-30 | 236,250 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | D To issuer deriv | 2019-07-30 | 2019-07-30 | 313,989 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | D To issuer deriv | 2019-07-30 | 2019-07-30 | 335,250 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | D To issuer deriv | 2019-07-30 | 2019-07-30 | 315,750 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | D To issuer | 2019-07-30 | 2019-07-30 | 130,542 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | D To issuer | 2019-07-30 | 2019-07-30 | 71,022 | $48.00 | $3.41M | 130,542 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2019-04-01 | 2019-04-03 | 9,844 | — | $0 | 9,844 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2019-04-01 | 2019-04-03 | 9,844 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | F Tax w/h | 2019-04-01 | 2019-04-03 | 8,660 | $24.60 | $213.0K | 71,022 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2019-04-01 | 2019-04-03 | 19,688 | — | $0 | 79,682 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2019-02-06 | 2019-02-08 | 87,500 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2019-02-06 | 2019-02-08 | 37,500 | — | $0 | 12,500 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | S Sale | 2019-02-06 | 2019-02-08 | 239,626 | $20.03 | $4.80M | 59,994 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2019-02-06 | 2019-02-08 | 87,500 | $4.63 | $405.1K | 299,620 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2019-02-06 | 2019-02-08 | 37,500 | $8.20 | $307.5K | 212,120 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2018-12-16 | 2018-12-18 | 13,968 | — | $0 | 41,907 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2018-12-16 | 2018-12-18 | 13,083 | — | $0 | 26,166 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | F Tax w/h | 2018-12-16 | 2018-12-18 | 11,898 | $15.97 | $190.0K | 174,620 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2018-12-16 | 2018-12-18 | 27,051 | — | $0 | 186,518 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2018-12-14 | 2018-12-18 | 315,750 | — | $0 | 315,750 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2018-12-14 | 2018-12-18 | 52,625 | — | $0 | 52,625 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2018-06-27 | 2018-06-29 | 32,068 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | S Sale | 2018-06-27 | 2018-06-29 | 17,964 | $17.74 | $318.7K | 159,467 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2018-06-27 | 2018-06-29 | 32,068 | — | $0 | 191,535 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | F Tax w/h | 2018-06-27 | 2018-06-29 | 14,104 | $18.50 | $260.9K | 177,431 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2018-04-01 | 2018-04-03 | 9,844 | — | $0 | 19,688 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2018-04-01 | 2018-04-03 | 9,844 | — | $0 | 168,142 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | F Tax w/h | 2018-04-01 | 2018-04-03 | 8,675 | $16.32 | $141.6K | 159,467 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2017-12-18 | 2017-12-19 | 20,366 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2017-12-18 | 2017-12-19 | 200,000 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2017-12-18 | 2017-12-19 | 89,634 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2017-12-18 | 2017-12-19 | 87,500 | — | $0 | 87,500 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | S Sale | 2017-12-18 | 2017-12-19 | 282,874 | $10.72 | $3.03M | 158,298 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2017-12-18 | 2017-12-19 | 200,000 | $5.14 | $1.03M | 243,672 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2017-12-18 | 2017-12-19 | 20,366 | $4.91 | $100.0K | 264,038 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2017-12-18 | 2017-12-19 | 89,634 | $4.91 | $440.1K | 353,672 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2017-12-18 | 2017-12-19 | 87,500 | $4.63 | $405.1K | 441,172 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2017-12-16 | 2017-12-19 | 13,082 | — | $0 | 39,249 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2017-12-16 | 2017-12-19 | 55,875 | — | $0 | 55,875 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2017-12-16 | 2017-12-19 | 335,250 | — | $0 | 335,250 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2017-12-16 | 2017-12-19 | 13,082 | — | $0 | 49,766 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | F Tax w/h | 2017-12-16 | 2017-12-19 | 6,094 | $10.92 | $66.5K | 43,672 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2017-04-01 | 2017-04-04 | 9,843 | — | $0 | 29,532 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | F Tax w/h | 2017-04-01 | 2017-04-04 | 6,293 | $8.94 | $56.3K | 39,558 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2017-04-01 | 2017-04-04 | 9,843 | — | $0 | 45,851 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | F Tax w/h | 2017-04-01 | 2017-04-06 | 9,167 | $8.94 | $82.0K | 36,684 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2016-12-27 | 2016-12-29 | 52,331 | — | $0 | 52,331 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2016-12-27 | 2016-12-29 | 313,989 | — | $0 | 313,989 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2016-04-01 | 2016-04-05 | 236,250 | — | $0 | 236,250 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2016-04-01 | 2016-04-05 | 39,375 | — | $0 | 39,375 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | F Tax w/h | 2016-04-01 | 2016-04-05 | 3,367 | $3.00 | $10.1K | 36,008 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2015-04-01 | 2015-04-03 | 236,250 | — | $0 | 236,250 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award | 2015-04-01 | 2015-04-03 | 39,375 | — | $0 | 39,375 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2015-03-02 | 2015-04-03 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | S Sale | 2015-03-02 | 2015-03-04 | 21,576 | $8.25 | $178.0K | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2015-03-01 | 2015-03-04 | 32,069 | — | $0 | 32,069 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | F Tax w/h | 2015-03-01 | 2015-03-04 | 10,493 | $7.96 | $83.5K | 21,576 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2015-03-01 | 2015-03-04 | 32,069 | $7.96 | $255.3K | 32,069 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2014-08-18 | 2014-08-20 | 64,137 | — | $0 | 64,137 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2014-04-01 | 2014-04-03 | 175,000 | — | $0 | 175,000 | SEC↗ |